immunity News and Research

RSS

Study reveals pivotal role of the circadian clock in enhancing checkpoint inhibitor cancer therapy

A multidisciplinary research team at the University of California, Irvine has revealed that the circadian clock – the biological pacemaker that governs daily rhythms in physiological processes, including immune functions – can be leveraged to enhance the efficacy of checkpoint inhibitor cancer therapy.

28 May 2024

New frontiers in medicine: COVID-19 lessons push for multidisciplinary collaboration

Researchers highlight the need for multidisciplinary collaboration in medicine, especially in addressing transmissible illnesses, precision medicine, and data science, as learned from the COVID-19 pandemic.

28 May 2024

Running therapy matches antidepressants for mental health, surpasses for physical benefits

Researchers found that while both antidepressants and group running therapy effectively improved mental health in patients with anxiety and depression, running therapy had significantly better outcomes for physical health indicators.

26 May 2024

Study finds human body lice can transmit plague bacteria

Researchers adapted a strain of human body lice to study their infection dynamics with Yersinia pestis, finding that lice can become infected and transmit the plague bacterium.

26 May 2024

New immunogenic strain of vaccinia virus unveils potent cancer therapy potential

Vaccinia viruses are therapeutic tools with different biomedical applications depending on the susceptibility characteristics.

24 May 2024

Insilico Medicine's leadership to address key challenges in AI drug discovery at BIO Convention

Leadership from clinical stage artificial intelligence (AI)-powered drug discovery company Insilico Medicine ("Insilico") will attend the BIO International Convention in San Diego June 3-6 and present on key issues facing AI drug discovery.

23 May 2024

Clues from bird flu’s ground zero on dairy farms in the Texas Panhandle

In early February, dairy farmers in the Texas Panhandle began to notice sick cattle. The buzz soon reached Darren Turley, executive director of the Texas Association of Dairymen: "They said there is something moving from herd to herd."

23 May 2024

Research aims to better understand the origin of eosinophils

Eosinophils are specialized cells of our immune system. They are identified by their distinctive granules that stain red when treated with an acidic reagent, eosin, which gave them their name.

22 May 2024

100-year-old BCG vaccine protects individuals with type 1 diabetes from infectious diseases

In new research, investigators at Massachusetts General Hospital (MGH) show that the 100-year-old Bacillus Calmette-Guérin (BCG) vaccine, originally developed to prevent tuberculosis, protects individuals with type 1 diabetes from severe COVID-19 disease and other infectious diseases.

22 May 2024

4 ways vaccine skeptics mislead you on measles and more

Measles is on the rise in the United States. So far this year, the number of cases is about 17 times what it was, on average, during the same period in each of the four years before, according to the Centers for Disease Control and Prevention.

22 May 2024

Exercise enhances efficacy of antibody therapy in leukemia patients

Bouts of moderate-to-vigorous intensity exercise could improve the efficacy of antibody therapies used to treat chronic lymphocytic leukemia, new research has shown.

21 May 2024

New discovery could lead to a treatment for visceral leishmaniasis

A discovery by Simona Stäger's team could help come up with a treatment to the most serious form of leishmaniasis.

21 May 2024

Study uncovers key biological pathways driving psoriasis inflammation

A certain biological pathway, a set of linked reactions in the body, drives the inflammation seen in the skin disease psoriasis, a new study finds.

20 May 2024

Insilico and NVIDIA unveil new LLM transformer for solving biological and chemical tasks

In a new paper, researchers from clinical stage artificial intelligence (AI)-driven drug discovery company Insilico Medicine ("Insilico"), in collaboration with NVIDIA, present a new large language model (LLM) transformer for solving biological and chemical tasks called nach0.

20 May 2024

immunity News and Research

Study reveals pivotal role of the circadian clock in enhancing checkpoint inhibitor cancer therapy

New frontiers in medicine: COVID-19 lessons push for multidisciplinary collaboration

Running therapy matches antidepressants for mental health, surpasses for physical benefits

Study finds human body lice can transmit plague bacteria

New immunogenic strain of vaccinia virus unveils potent cancer therapy potential

Insilico Medicine's leadership to address key challenges in AI drug discovery at BIO Convention

Clues from bird flu’s ground zero on dairy farms in the Texas Panhandle

Research aims to better understand the origin of eosinophils

100-year-old BCG vaccine protects individuals with type 1 diabetes from infectious diseases

4 ways vaccine skeptics mislead you on measles and more

Exercise enhances efficacy of antibody therapy in leukemia patients

New discovery could lead to a treatment for visceral leishmaniasis

Study uncovers key biological pathways driving psoriasis inflammation

Insilico and NVIDIA unveil new LLM transformer for solving biological and chemical tasks

Study confirms strong barrier preventing chronic wasting disease transmission to humans

Study reveals positive impact of repeat COVID-19 vaccinations

POSTECH and ImmunoBiome make significant breakthrough in the fight against cancer

HPV vaccination reduces cervical cancer across all socioeconomic groups in England

Does discrimination cause harm to the body?

COVID-19 linked to rise in autoimmune lung disease, study finds

Changing the landscape of R&D to build clinical success from the ground up

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Latest News